Annual report pursuant to Section 13 and 15(d)

Net Income (Loss) Per Share (Antidilutive Securities) (Details)

v3.22.0.1
Net Income (Loss) Per Share (Antidilutive Securities) (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Aug. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted earnings per share (in shares)   9,898,549 12,454,733 8,244,079
Convertible Notes due 2025        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Debt conversion amount     $ 4.8 $ 4.8
Shares converted (in shares) 4,800,000      
Options to purchase common stock        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted earnings per share (in shares)   0 438,040 1,150,586
Unvested RSU's and PSU's        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted earnings per share (in shares)   0 1,648,144 1,572,988
Convertible Notes        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted earnings per share (in shares)   9,898,549 9,898,549 5,050,505
Warrants        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted earnings per share (in shares)   0 470,000 470,000